Investment Summary |
|
|---|---|
| Date | 2012-10-18 |
| Target | Kunwha Pharmaceuticals Co. |
| Sector | Life Science |
| Investor(s) | Alvogen |
| Deal Type | Stake Purchase |
SEARCH BY
Alvogen is a multinational pharmaceuticals company focused on developing, manufacturing, and distributing generic, brand, over-the-counter brands (OTC), and biosimilar products. Alvogen was founded in 2009 and is based in Pine Brook, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 8 |
| Sector: Life Science M&A | 2 of 8 |
| Type: Stake Purchase M&A Deals | 1 of 1 |
| Country: South Korea M&A | 1 of 2 |
| Year: 2012 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-10-22 |
Par Pharmaceutical Co. - Research and Development Capabilities
United States Par Pharmaceutical Co., Inc. - Research and Development Capabilities provides pharmaceutical services. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-12-31 |
LaborMed Pharma
Ljubljana, Romania LaborMed Pharma is a manufacturer and distributor generic pharmaceuticals primarily for cardiovascular and central nervous system aliments. The Company has also launched a portfolio of drugs for diabetes. LaborMed Pharma is based in Ljubljana, Romania. |
Buy | - |
